UiPath Tidigare resultatutveckling
Tidigare kriterier kontrolleras 5/6
UiPath har ökat intäkterna med en genomsnittlig årlig takt på 65.4%, medan Software -branschen såg intäkterna växer på 31.8% årligen. Intäkterna har varit växande med en genomsnittlig takt på 14.8% per år. UiPath s avkastning på eget kapital är 18.6% och den har en nettomarginal på 21%.
Viktig information
65.40%
Tillväxttakt i vinsten
70.30%
Tillväxttakt för EPS
| Software Tillväxt i branschen | 17.33% |
| Intäkternas tillväxttakt | 14.76% |
| Avkastning på eget kapital | 18.57% |
| Nettomarginal | 21.03% |
| Senaste uppdateringen av resultatet | 31 Jul 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Uppdatering av berättelse • Sep 03
PATH: AI Orchestration And Execution Will Shape A Measured Repricing Outlook
UiPath's updated analyst price target moves higher to align with recent Street increases toward $15 to $19. This shift is supported by checks that analysts say point to a firmer revenue outlook, slightly stronger profitability and a modestly higher assumed future P/E multiple.Seeking Alpha • Aug 31
UiPath: Maybe Not That Great Ahead Of Earnings
Summary UiPath Inc. has evolved from RPA pioneer to a leader in Agentic AI, offering a comprehensive automation platform with new orchestration products like Mestro Flow. PATH faces intensifying competition from Microsoft, OpenAI, and other large AI players, with its moat real but increasingly contested and volatility tied to competitive headlines. Q1 FY2026 delivered 17% YoY revenue growth, first-ever GAAP profitable first quarter, $1.9B ARR (+12% YoY), and a net retention rate rising to 109%. Management highlights early signs of re-acceleration, with $1M+ ARR customers up 18% YoY and remaining performance obligations increasing 15% to $1.4B. Read the full article on Seeking Alpha
Uppdatering av berättelse • Aug 28
The AI Opportunity Is Still There, but the Upside Looks More Limited
My original thesis for UiPath was that it could become one of the major beneficiaries of the second phase of the AI boom, where AI moves beyond generating answers and starts actually doing work. That thesis hasn’t disappeared.Uppdatering av berättelse • Jul 10
PATH: AI Automation And ARR Execution Will Drive Future Repricing
UiPath's analyst fair value estimate has been trimmed from $17.00 to about $16.29 as analysts adjust their price targets into a tighter $12 to $15 range. This reflects solid recent results, but also a preference to see stronger, more consistent ARR momentum and clearer AI driven benefits before becoming more positive.
Uppdatering av berättelse • Jun 26
PATH: Agentic AI Adoption Will Strengthen Future ARR Visibility Despite Cautious Sentiment
UiPath's consensus narrative has shifted slightly lower as the average analyst price target edges down by about $0.50. This reflects solid Q1 results and improved profitability assumptions, offset by more cautious expectations for revenue growth and future P/E multiples, while analysts wait for clearer evidence of faster ARR growth from AI driven deals.Analysartikel • Jun 17
UiPath (PATH) Stock Could Be 24% Undervalued After Maestro Case Launch
UiPath (PATH) is back in focus after launching Maestro Case, an AI-native case management capability that targets complex, exception-heavy workflows, with early adopters reporting sizable efficiency gains and projected cost savings. See our latest analysis for UiPath. Despite Maestro Case and recent customer wins such as One New Zealand Limited, short term selling pressure has left UiPath’s share price down 33.75% year to date and the 5 year total shareholder return down 84.94%. This points...Analysartikel • Jun 11
UiPath's (NYSE:PATH) Promising Earnings May Rest On Soft Foundations
UiPath, Inc. ( NYSE:PATH ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...
Ny berättelse • May 18
AI Automation Demand And Margin Expansion Will Support Steady Performance Over Time
Catalysts About UiPath UiPath provides an automation and AI software platform that helps enterprises build, orchestrate and govern digital workflows. What are the underlying business or industry changes driving this perspective?Uppdatering av berättelse • May 02
PATH: Agentic AI Automation Adoption Will Drive Future ARR Stability
Analysts have trimmed their average price targets on UiPath by several dollars, bringing them into a roughly $12 to $17 range. They cited strong Q4 execution and growing AI driven automation use cases, along with valuation compression across software peers and a need for clearer evidence of sustained AI monetization and net new ARR growth.Uppdatering av berättelse • Apr 18
PATH: Agentic AI Automation And ARR Stability Will Drive Future Upside
Analysts have reduced UiPath's average price target by a few dollars to a roughly mid-teens dollar value. They cite solid Q4 execution and ARR trends, but also point to valuation compression across software peers, along with a need for clearer AI monetization and sustained net new ARR growth.Uppdatering av berättelse • Apr 03
PATH: Agentic AI Automation And ARR Stability Will Support Future Upside
Analysts have nudged the average price target for UiPath slightly lower to around the mid teens in $ terms, trimming expectations on valuation multiples, even as they cite solid Q4 execution, steady ARR trends and growing interest in AI driven automation as key supports for the story. Analyst Commentary Recent research points to a mixed but generally balanced view on UiPath, with most firms trimming price targets while acknowledging solid Q4 execution, resilient ARR and growing interest in AI driven automation.Uppdatering av berättelse • Mar 20
PATH: Agentic AI Automation And Healthcare Solutions Will Support Future Upside
UiPath's updated analyst fair value estimate has shifted from $15.93 to $13.81 as analysts reset price targets across the $12 to $18 range, weighing solid Q4 execution, AI driven automation traction and improving margins against valuation compression, flat to stabilizing net new ARR, and the need for clearer proof of sustained AI monetization. Analyst Commentary Recent research points to a split view on UiPath, with most firms reducing price targets but highlighting both encouraging execution in Q4 and unresolved questions around future growth and valuation.Ny berättelse • Mar 12
AI Automation Platform Will Benefit From Long Term Cross System Workflow Complexity
Catalysts About UiPath UiPath provides an end to end automation and AI platform that helps enterprises automate complex workflows across systems, people and software. What are the underlying business or industry changes driving this perspective?Uppdatering av berättelse • Mar 06
PATH: Healthcare AI Launch And Index Additions Will Support Future Upside
Analysts have trimmed their blended price target for UiPath by about $0.27 to reflect a slightly lower fair value estimate of $15.93, modestly higher discount rate assumptions, and only small tweaks to long term margin and P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts see scope for UiPath to reach a price target of US$18, which sits above the trimmed blended fair value estimate of US$15.93, suggesting room for upside if execution aligns with their assumptions.Uppdatering av berättelse • Feb 19
PATH: Index Additions And Buybacks Will Support Future Automation Upside
Analysts have trimmed their UiPath fair value estimate slightly to $16.19 from $16.40, citing mixed expectations around future profitability and valuation multiples, even as revenue assumptions stay relatively steady. Analyst Commentary Street research on UiPath reflects a mix of optimism around sector conditions and caution around how that translates into the company’s valuation and execution over time.Analysartikel • Feb 06
Some Confidence Is Lacking In UiPath, Inc. (NYSE:PATH) As Shares Slide 30%
UiPath, Inc. ( NYSE:PATH ) shares have had a horrible month, losing 30% after a relatively good period beforehand. The...Uppdatering av berättelse • Feb 05
PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative Update on UiPath UiPath’s implied analyst price target has ticked higher as recent research cites a move from $16 to $18 at one firm and from $12 to $14 at another, with analysts pointing to a generally supportive backdrop for software and ongoing interest in AI related opportunities as key drivers for the updated views. Analyst Commentary Recent research on UiPath centers on how the shares might reflect a mixed backdrop for software, AI related themes, and current valuation levels.Uppdatering av berättelse • Jan 21
PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative update Analysts have nudged their fair value view for UiPath slightly higher, reflecting price target moves such as Barclays lifting its target to US$18 from US$16 and RBC Capital moving to US$14 from US$12, citing a more constructive setup for software and AI exposed names. Analyst Commentary Recent research is broadly constructive, but it also highlights that expectations around AI and software can still be a source of swings in sentiment for UiPath.Uppdatering av berättelse • Jan 07
PATH: AI Trade Enthusiasm And Index Adds Will Shape Automation Outlook
Analysts have inched their fair value estimate for UiPath lower from $16.40 to about $16.27 per share, while still lifting some price targets, such as the move to $14 at RBC Capital. This reflects mixed views as they weigh AI related enthusiasm against updated assumptions for growth, margins and future P/E multiples.Analysartikel • Dec 23
UiPath Inc.'s (NYSE:PATH) 28% Price Boost Is Out Of Tune With Revenues
The UiPath Inc. ( NYSE:PATH ) share price has done very well over the last month, posting an excellent gain of 28%. The...Uppdatering av berättelse • Dec 21
PATH: AI Partnerships Will Support Automation Gains While Competition Keeps Outlook Balanced
Analysts have modestly increased their fair value estimate for UiPath from approximately $15.93 to $16.40 per share, reflecting a slightly higher long term growth outlook supported by recent price target raises tied to AI driven product enhancements and partnerships, despite ongoing competitive pressures. Analyst Commentary Recent Street commentary reflects a cautiously constructive stance on UiPath, with modest target price increases framed by both optimism around AI driven automation and recognition of intense competitive dynamics.Uppdatering av berättelse • Dec 07
PATH: AI Partnerships Will Drive Automation Hype Yet Leave Shares Vulnerable
UiPath's updated fair value estimate has risen to approximately $15.93 from $13.86, as analysts modestly lift price targets in response to new product launches, strategic partnerships, and expectations that the company can increasingly leverage AI trends, despite a still competitive market. Analyst Commentary Analysts remain measured on UiPath, modestly increasing price targets while keeping neutral ratings as they weigh improving product momentum against a still challenging competitive backdrop.Uppdatering av berättelse • Nov 23
PATH: Partnerships And New AI Offerings Will Shape Automation Leadership Ahead
Analysts have modestly increased their price target for UiPath, raising it from approximately $13.71 to $13.86 per share. They cite recent product updates and ongoing developments in the AI and automation space as supportive factors for the adjustment.Uppdatering av berättelse • Nov 08
PATH: Product Partnerships And Updates Will Shape Future Opportunities In Automation
UiPath's analyst price target has increased to $13 from $12.50, as analysts recognize ongoing product updates and partnerships but remain cautious about the company's growth prospects in a competitive market. Analyst Commentary Recent analyst updates reflect a nuanced perspective on UiPath's future, highlighting both supportive and cautious sentiments about the company's execution and long-term growth prospects.Uppdatering av berättelse • Oct 25
Expanding Automation Partnerships And AI-Powered Agents Will Drive Business Momentum
UiPath’s analyst price target has been revised upward to $13 from $12.50, as analysts cite ongoing product innovation and new partnerships. This comes despite expectations of gradual top-line impact amid ongoing market competition.Uppdatering av berättelse • Oct 10
Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s analyst price target has been modestly increased from $13.30 to $13.44, as analysts cite ongoing product and partnership developments. However, they also note persistent competitive pressures in the automation market.Analysartikel • Oct 07
What UiPath Inc.'s (NYSE:PATH) 26% Share Price Gain Is Not Telling You
UiPath Inc. ( NYSE:PATH ) shareholders would be excited to see that the share price has had a great month, posting a...Uppdatering av berättelse • Sep 06
Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s price target has been revised down due to a sharp year-over-year decline in net new ARR and heightened long-term market uncertainty, reflecting a lowered fair value from $14.15 to $13.30. Analyst Commentary Net new annual recurring revenue rose by $30M, but this represents a 30% year-over-year decline.Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur UiPath tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Jul 26 | 1,721 | 362 | 889 | 366 |
| 30 Apr 26 | 1,672 | 327 | 897 | 381 |
| 31 Jan 26 | 1,611 | 282 | 891 | 383 |
| 31 Oct 25 | 1,553 | 230 | 879 | 386 |
| 31 Jul 25 | 1,497 | 20 | 882 | 386 |
| 30 Apr 25 | 1,451 | -68 | 910 | 385 |
| 31 Jan 25 | 1,430 | -74 | 942 | 375 |
| 31 Oct 24 | 1,411 | -92 | 971 | 362 |
| 31 Jul 24 | 1,383 | -112 | 984 | 350 |
| 30 Apr 24 | 1,354 | -87 | 964 | 339 |
| 31 Jan 24 | 1,308 | -90 | 943 | 332 |
| 31 Oct 23 | 1,211 | -151 | 900 | 325 |
| 31 Jul 23 | 1,148 | -178 | 871 | 308 |
| 30 Apr 23 | 1,103 | -238 | 881 | 290 |
| 31 Jan 23 | 1,059 | -328 | 918 | 285 |
| 31 Oct 22 | 1,040 | -364 | 926 | 263 |
| 31 Jul 22 | 998 | -429 | 916 | 256 |
| 30 Apr 22 | 951 | -408 | 870 | 246 |
| 31 Jan 22 | 892 | -526 | 948 | 277 |
| 31 Oct 21 | 810 | -436 | 823 | 240 |
| 31 Jul 21 | 737 | -384 | 780 | 207 |
| 30 Apr 21 | 681 | -284 | 704 | 176 |
| 31 Jan 21 | 608 | -92 | 542 | 110 |
| 31 Jan 20 | 336 | -520 | 653 | 131 |
Kvalitetsintäkter: PATH har inkomster av hög kvalitet.
Växande vinstmarginal: PATH s nuvarande netto vinstmarginaler (21%) är högre än förra året (1.3%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: PATH har blivit lönsamt under de senaste 5 åren och ökat intäkterna med 65.4% per år.
Accelererande tillväxt: PATH s intäktstillväxt under det senaste året ( 1694.5% ) överstiger sitt 5-åriga genomsnitt ( 65.4% per år).
Resultat vs industri: PATH vinsttillväxt under det senaste året ( 1694.5% ) översteg Software branschen 27.2%.
Avkastning på eget kapital
Hög ROE: PATH s avkastning på eget kapital ( 18.6% ) anses vara låg.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/09/09 13:21 |
| Aktiekurs vid dagens slut | 2026/09/09 00:00 |
| Intäkter | 2026/07/31 |
| Årlig intjäning | 2026/01/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
UiPath, Inc. bevakas av 31 analytiker. 21 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Raimo Lenschow | Barclays |
| William Kingsley Crane | Berenberg |
| Keith Bachman | BMO Capital Markets Equity Research |